-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On July 26, Beilu Pharmaceutical issued an announcement stating that the company had received the "Drug Supplementary Application Approval Notice" for two specifications of Gadopentetate meglumine injection issued by the National Medical Products Administration.
The company's gadopentetate meglumine injection obtained the National Class II New Drug Certificate issued by the Ministry of Health in 1992; it is mainly used for magnetic resonance imaging of human organs and tissues such as the central nervous system (brain and spinal cord), abdomen, chest, pelvis, limbs, etc.
According to relevant national policies, appropriate support will be given to medical insurance payment for drug varieties that have passed the consistency evaluation, and medical institutions will give priority to purchase and use in clinical practice